Informations

Stand number

D102

Exhibition class

M: Medicine – Surgery – Orthopaedics – Material for disabled

Technical description

An AI-driven platform (DoLPHIN) developed to analyze multi-omics data from a huge mother-baby cohort, with over 130,000 samples from 2,000+ families, aiming to create next-generation probiotics and live biotherapeutics to combat NCDs.

Simplified description

Researchers found that the gut bacteria of infants were different during the COVID pandemic, which made them more prone to eczema. They created a new therapy called SIM03, designed to adjust these bacteria and help reduce the severity of the disease.